On July 10, 2018, the U.S. District Court for the Northern District of California (in MDL 2741) denied Monsanto’s Summary Judgment Motion, allowing hundreds of non-Hodgkin lymphoma cases to proceed toward trial. Monsanto had successfully requested that the Court “bifurcate” the case; to oversimplify, Plaintiffs were required to get past a “general causation” challenge. The Miller Firm and its colleagues on the MDL Steering Committee designated six world renowned experts in scientific fields from toxicology to clinical oncology.
In a lengthy opinion, the Court denied Monsanto’s challenge and request to dismiss the case, concluding:
“Therefore, the plaintiffs have presented evidence from which a
reasonable jury could conclude that glyphosate can cause NHL at human-relevant doses. “
Monsanto’s request had been that the cases all be dismissed; instead, they are not only proceeding, but have cleared an evidentiary burden that is typically raised closer to trial. The Miller Firm expects to take these cases to trial for many years to come.
Michael Miller of the Miller Firm is one of three attorneys leading the nationwide effort,s on the Executive Committee, Plaintiff’s Steering Committee. All cases that are filed in the Federal court system have been consolidated or coordinated into this MDL. Miller Firm trial attorneys David Dickens and Jeffrey Travers are presently in San Francisco conducting the world’s first jury trial on this subject, Dewayne Johnson v. Monsanto. Mr. Miller is also a co-lead of the JCCP 4953, In re Roundup Products Liability, which contains several hundred cases in the California state court system.
Follow this website for updates on the Roundup litigation, and follow national/international media outlets for breaking news on the Johnson v. Monsanto trial.
Have a potential case or interested in exploring a co-counsel relationship? Contact [email protected]
